Drreddys Laboratories reported $571M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Ani Pharmaceuticals ANIP:US $ 76.91M 23.39M
Aurora Cannabis Inc ACB:CN 429.89M 97.49M
Bayer BAYN:GR € 5785M 1221M
Canopy Growth Corp WEED:CN C$ 776M 582.53M
Catalent CTLT:US $ 786M 63M
Corcept Therapeutics CORT:US $ 61.86M 15.76M
Endo International Ordinary Shares ENDP:US $ 1413.15M 94.05M
GlaxoSmithKline GSK:LN 10967M 6693M
Hikma Pharmaceutical HIK:LN 22M 20M
Horizon Pharma HZNP:US $ 1643.13M 62.81M
Lannett LCI:US $ 106.11M 7.47M
Lonza Group LONN:SW 1.58B 1.08B
Novartis NOVN:VX SF 13852M 1445M
Pacira Pharmaceuticals PCRX:US $ 226.75M 358.83M
Phibro Animal Health PAHC:US $ 70.75M 7.36M
Prestige Brands PBH:US $ 27.18M 6.17M
Richter Gedeon RICHT:HB 74.03B 14.17B
Supernus Pharmaceuticals SUPN:US $ 115.72M 87.72M
Teva Pharmaceutical TEVA:IT 2.18B 10M